Ruthless Spine earned FDA 510(k) clearance for the NavJam Jamshidi device, according to a Sept. 18 news release.
NavJam works with Ruthless Spine’s de novo-cleared RJB intraoperative angle measurement instrument. Together they can minimize radiation, increase precision and simplify workflows.
The platform doesn’t require capital investment or specialized staff and has been adopted globally in Turkey, Ukraine and Africa.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
